Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

SARS-CoV-2 infection and venous thromboembolism after surgery : an international prospective cohort study

Title: SARS-CoV-2 infection and venous thromboembolism after surgery : an international prospective cohort study
Authors: Li, E.; Borges, Mafada; Brits, Tim; De Hous, Nicolas; de Wachter, Stefan; Komen, Niels; Menovsky, Tomas; Mortiers, Xavier; Vermeulen, Dorien; Vleminckx, Nils; Ysebaert, Dirk; COVIDSurg Collaborative; GlobalSurg Collaborative
Contributors: COVIDSurg Collaborative; GlobalSurg Collaborative
Source: 0003-2409 ; Anaesthesia
Publication Year: 2022
Collection: IRUA - Institutional Repository van de Universiteit Antwerpen
Subject Terms: Human medicine
Description: SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. SARS-CoV-2 diagnosis was defined as peri-operative (7 days before to 30 days after surgery); recent (1-6 weeks before surgery); previous (>= 7 weeks before surgery); or none. Information on prophylaxis regimens or pre-operative anti-coagulation for baseline comorbidities was not available. Postoperative venous thromboembolism rate was 0.5% (666/123,591) in patients without SARS-CoV-2; 2.2% (50/2317) in patients with peri-operative SARS-CoV-2; 1.6% (15/953) in patients with recent SARS-CoV-2; and 1.0% (11/1148) in patients with previous SARS-CoV-2. After adjustment for confounding factors, patients with peri-operative (adjusted odds ratio 1.5 (95%CI 1.1-2.0)) and recent SARS-CoV-2 (1.9 (95%CI 1.2-3.3)) remained at higher risk of venous thromboembolism, with a borderline finding in previous SARS-CoV-2 (1.7 (95%CI 0.9-3.0)). Overall, venous thromboembolism was independently associated with 30-day mortality (5.4 (95%CI 4.3-6.7)). In patients with SARS-CoV-2, mortality without venous thromboembolism was 7.4% (319/4342) and with venous thromboembolism was 40.8% (31/76). Patients undergoing surgery with peri-operative or recent SARS-CoV-2 appear to be at increased risk of postoperative venous thromboembolism compared with patients with no history of SARS-CoV-2 infection. Optimal venous thromboembolism ...
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/isi/000687801000001
Availability: https://hdl.handle.net/10067/1870100151162165141; https://repository.uantwerpen.be/docstore/d:irua:11447
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.27CF7084
Database: BASE